1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Background In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during acute COVID-19 would be associated with i...
Saved in:
Similar Items
-
Integrating patients with chronic respiratory disease and heart failure into a combined breathlessness rehabilitation programme: a service redesign and pilot evaluation
by: Linzy Houchen-Wolloff, et al.
Published: (2021-01-01) -
Exploring Machine Learning Classification of Movement Phases in Hemiparetic Stroke Patients: A Controlled EEG-tDCS Study
by: Rishishankar E. Suresh, et al.
Published: (2024-12-01) -
Importance and satisfaction of motivation and setting factors among elk and deer hunters
by: Abigail R. Kaminski, et al.
Published: (2024-12-01) -
New Drug Trends across Welsh Prisons: Evaluating the Role of People with Lived Experience of Substance Misuse and Supporting their Recovery
by: M. Vigar, et al.
Published: (2024-12-01) -
From Rarity to Recognition: Infantile Botulism and the Broad Spectrum of Differential Diagnoses
by: Matthew C. Authement, et al.
Published: (2024-01-01)